Document is current
Any future updates will be listed below
-
Authors
Ambalavanan, N
Aschner, J L
- License Information
-
More Information
Article History
Received: 15 October 2015
Revised: 10 February 2016
Accepted: 16 February 2016
First Online: 26 May 2016
Competing interests
: JLA and NA received honoraria for their participation in a roundtable meeting supported by a grant from Mallinckrodt Pharmaceuticals, formerly Ikaria. JLA owns stock in Gilead, and is named on an intellectual property rights patent for the use of intravenous citrulline for neonatal lung diseases. NA has received research support from Pfizer, and has received research support as a mentor from Ikaria. NIH Grants: 1U01HL101456 (JLA); U01 HL122626 and R01 HD067126 (NA).
